In this study, we leveraged an AI-driven drug target screening platform, PandaOmics, to identify CACNA2D1 as a potential oncogenic agent activated by enhancer infestation in Epstein–Barr virus-associated nasopharyngeal carcinoma (NPC). This evidence concerns the gene CACNA2D1 and nasopharyngeal carcinoma.